Medium comprising transforming growth factor β1 and basic fibroblast growth factor
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-005/02
C12N-005/074
C12N-005/0735
출원번호
US-0058347
(2013-10-21)
등록번호
US-8945925
(2015-02-03)
발명자
/ 주소
Amit, Michal
Itskovitz-Eldor, Joseph
출원인 / 주소
Technion Research & Development Foundation Limited
인용정보
피인용 횟수 :
2인용 특허 :
23
초록▼
The present invention is of methods of establishing and propagating human embryonic stem cell lines using feeder cells-free, xeno-free culture systems and stem cells which are capable of being maintained in an undifferentiated, pluripotent and proliferative state in culture which is free of xeno con
The present invention is of methods of establishing and propagating human embryonic stem cell lines using feeder cells-free, xeno-free culture systems and stem cells which are capable of being maintained in an undifferentiated, pluripotent and proliferative state in culture which is free of xeno contaminants and feeder cells.
대표청구항▼
1. A culture medium which comprises transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF), wherein the culture medium is free of animal- and/or feeder cells contaminants, and said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state f
1. A culture medium which comprises transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF), wherein the culture medium is free of animal- and/or feeder cells contaminants, and said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state for at least 5 passages. 2. The culture medium of claim 1, further comprises serum replacement. 3. The culture medium of claim 2, wherein said serum replacement is provided at a concentration of at least 10%. 4. The culture medium of claim 2, wherein said serum replacement is provided at a concentration of 15%. 5. The culture medium of claim 1, further comprises human serum. 6. The culture medium of claim 5, wherein said human serum is provided at a concentration of at least 10%. 7. The culture medium of claim 5, wherein said human serum is provided at a concentration of 15%. 8. The culture medium of claim 1, wherein said TGFβ1 is provided at a concentration range of at least 0.06 ng/ml. 9. The culture medium of claim 1, wherein said TGFβ1 is provided at a concentration range of 0.06-0.24 ng/ml. 10. The culture medium of claim 1, wherein said bFGF is provided at a concentration of at least 2 ng/ml. 11. The culture medium of claim 1, wherein said bFGF is provided at a concentration rage of 2-8 ng/ml. 12. The culture medium of claim 1, further comprising leukemia inhibitor factor (LIF). 13. The culture medium of claim 12, wherein said LIF is provided at a concentration of at least 500 units/ml. 14. The culture medium of claim 12, wherein said LIF is provided at a concentration range of 500-2000 units/ml. 15. A culture medium comprising transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF), wherein the culture medium comprises serum replacement, wherein said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state for at least 5 passages. 16. The culture medium of claim 15, wherein said serum replacement comprises albumin or albumin substitutes, amino acids, vitamins, transferrins or transferrin substitutes, antioxidants, insulin or insulin substitutes, collagen precursors and trace elements. 17. The culture medium of claim 15, wherein the culture medium is substantially free of animal contaminants. 18. The culture medium of claim 15, wherein said bFGF is provided at a concentration of at least 2 ng/ml. 19. A culture medium comprising transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF), animal-free albumin and being devoid of serum, wherein said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state for at least 5 passages. 20. A culture medium comprising transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF), wherein the culture medium comprises albumin or albumin substitutes, amino acids, vitamins, transferrins or transferrin substitutes, antioxidants, insulin or insulin substitutes, collagen precursors and trace elements, wherein said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state for at least 5 passages. 21. A culture medium comprising transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF) and being devoid of serum, wherein the culture medium comprises serum replacement, wherein said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state for at least 5 passages. 22. The culture medium of claim 21, wherein said serum replacement comprises albumin or albumin substitutes, amino acids, vitamins, transferrins or transferrin substitutes, antioxidants, insulin or insulin substitutes, collagen precursors and trace elements. 23. A culture medium comprising transforming growth factor β1 (TGFβ1), and basic fibroblast growth factor (bFGF) and being devoid of serum, wherein the culture medium comprises albumin or albumin substitutes, amino acids, vitamins, transferrins or transferrin substitutes, antioxidants, insulin or insulin substitutes, collagen precursors and trace elements, wherein said culture medium is capable of maintaining pluripotent stem cell in an undifferentiated state for at least 5 passages. 24. The culture medium of claim 23, further comprises serum replacement.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (23)
Amit, Michal; Itskovitz-Eldor, Joseph, Co-culturing mammalian embryonic stem cells with human foreskin fibroblasts.
Gold, Joseph D.; Hassanipour, Mohammad; Collins, Lila R.; Xu, Chunhui, Direct differentiation method for making cardiomyocytes from human embryonic stem cells.
Gold,Joseph D.; Hassanipour,Mohammad; Collins,Lila R.; Xu,Chunhui, Direct differentiation method for making cardiomyocytes from human embryonic stem cells.
Mandalam, Ramkumar; Xu, Chunhui; Gold, Joseph D.; Carpenter, Melissa K., Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor.
Eriksson, Peter; Kilmare, Eva Karin; Tallheden, Tommi; Enerbäck, Sven, Method for efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system, long-term propagation of hBS cells under feeder-free conditions and use of cultured hBS cells for applications in myocardial regeneration.
Amit, Michal; Itskovitz-Eldor, Joseph, Methods of culturing cells in a medium comprising transforming growth factor beta 1 and basic fibroblast growth factor.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.